Using DANU smart socks to measure walking, balance, and fall risk in Parkinson's

Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction

Observational Northumbria University · NCT07281755

This project will test whether DANU smart socks can accurately measure gait and balance and help predict falls in people with Parkinson's.

Quick facts

Study typeObservational
Enrollment60 (estimated)
Ages50 Years and up
SexAll
SponsorNorthumbria University Academic / other
Locations1 site (Newcastle upon Tyne)
Trial IDNCT07281755 on ClinicalTrials.gov

What this trial studies

This observational, repeated-measures project will compare metrics from DANU smart socks to laboratory gold-standard gait and balance equipment using the V3+ framework for biometric device validation. Participants with Parkinson's will attend two visits at Northumbria University to complete a series of motor tasks while wearing the socks, alongside clinical scales such as the MDS-UPDRS, MoCA, Freezing of Gait Questionnaire, and Falls Efficacy Scale. The study will examine analytical validity, reliability, usability, and relationships between DANU outcomes, clinical scores, past fall history, and prospective falls. Results will determine whether the sock-derived measures match reference standards and whether they relate to clinical measures and future fall risk.

Who should consider this trial

Good fit: Adults with a clinical diagnosis of Parkinson's disease (Hoehn & Yahr stages I–III) who can stand and walk unassisted for at least two minutes, have MoCA ≥21, and can attend two visits to Northumbria University are eligible.

Not a fit: People with more advanced Parkinson's (Hoehn & Yahr IV–V), significant cognitive impairment (MoCA <21), other neurological disorders, or recent lower-limb injury are unlikely to benefit from this protocol.

Why it matters

Potential benefit: If successful, the device could provide objective, wearable measures of gait and balance to help identify people with Parkinson's who are at higher risk of falling.

How similar studies have performed: Wearable inertial sensors and pressure-sensing insoles have shown promise for gait measurement and fall risk prediction, but DANU smart socks are a relatively new form factor that requires formal validation.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of Parkinson's by a movement disorder specialist according to UK brain bank criteria.
* Hoehn \& Yahr stages I-III
* Able to attend Northumbria University, Newcastle Upon Tyne for study visits
* Able to walk and stand unassisted for a minimum of 2-minutes

Exclusion Criteria:

* History of neurological disorders other than PD (e.g., Huntington's disease, stroke, traumatic brain injury, multiple sclerosis, Alzheimer's disease etc.)
* Montreal Cognitive Assessment (MoCA) score \< 21
* Injury to the lower extremities within the past 6-weeks.

Where this trial is running

Newcastle upon Tyne

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Parkinson DiseaseDANUWearable Electronic DevicesGait AnalysisValidity and ReliabilityMobility AssessmentSmart Socks
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.